Serina Therapeutics, Inc. (SER)
1.41
-0.24
(-14.55%)
USD |
NYAM |
Nov 06, 10:31
Serina Therapeutics EPS Diluted (Quarterly) : -0.5451 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5451 |
| March 31, 2026 | -0.5757 |
| December 31, 2025 | -0.3133 |
| September 30, 2025 | -0.4435 |
| June 30, 2025 | -0.6445 |
| March 31, 2025 | -0.4933 |
| September 30, 2024 | 0.1312 |
| June 30, 2024 | 0.5124 |
| March 31, 2024 | -5.382 |
| December 31, 2023 | 0.4361 |
| September 30, 2023 | 0.2318 |
| June 30, 2023 | 0.1087 |
| March 31, 2023 | 0.2033 |
| December 31, 2022 | -2.505 |
| September 30, 2022 | -2.257 |
| June 30, 2022 | -2.427 |
| March 31, 2022 | -2.508 |
| December 31, 2021 | -2.000 |
| September 30, 2021 | -1.812 |
| Date | Value |
|---|---|
| June 30, 2021 | -2.294 |
| March 31, 2021 | -1.946 |
| December 31, 2020 | -2.282 |
| September 30, 2020 | -2.374 |
| June 30, 2020 | -2.512 |
| March 31, 2020 | -2.977 |
| December 31, 2019 | -2.533 |
| September 30, 2019 | -3.010 |
| June 30, 2019 | -2.887 |
| March 31, 2019 | -3.048 |
| December 31, 2018 | -3.127 |
| September 30, 2018 | -2.111 |
| June 30, 2018 | -1.895 |
| March 31, 2018 | -0.2307 |
| December 31, 2017 | -1.479 |
| September 30, 2017 | -1.918 |
| June 30, 2017 | -0.6056 |
| March 31, 2017 | -2.456 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.356M |
| Total Expenses (Quarterly) | 6.356M |
| Enterprise Value | 22.10M |
| Earnings Yield | -133.2% |
| Normalized Earnings Yield | -158.74 |